The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Glucagon-Like Peptides: Regulators of Cell Proliferation, Differentiation, and Apoptosis
Abstract
Peptide hormones are secreted from endocrine cells and neurons and exert their actions through activation of G protein-coupled receptors to regulate a diverse number of physiological systems including control of energy homeostasis, gastrointestinal motility, neuroendocrine circuits, and hormone secretion. The glucagon-like peptides, GLP-1 and GLP-2 are prototype peptide hormones released from gut endocrine cells in response to nutrient ingestion that regulate not only energy absorption and disposal, but also cell proliferation and survival. GLP-1 expands islet mass by stimulating pancreatic beta-cell proliferation and induction of islet neogenesis. GLP-1 also promotes cell differentiation, from exocrine cells or immature islet progenitors, toward a more differentiated beta-cell phenotype. GLP-2 stimulates cell proliferation in the gastrointestinal mucosa, leading to expansion of the normal mucosal epithelium, or attenuation of intestinal injury in experimental models of intestinal disease. Both GLP-1 and GLP-2 exert antiapoptotic actions in vivo, resulting in preservation of beta-cell mass and gut epithelium, respectively. Furthermore, GLP-1 and GLP-2 promote direct resistance to apoptosis in cells expressing GLP-1 or GLP-2 receptors. Moreover, an increasing number of structurally related peptide hormones and neuropeptides exert cytoprotective effects through G protein-coupled receptor activation in diverse cell types. Hence, peptide hormones, as exemplified by GLP-1 and GLP-2, may prove to be useful adjunctive tools for enhancement of cell differentiation, tissue regeneration, and cytoprotection for the treatment of human disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A role for glucagon-like peptide-1 in the central regulation of feeding
Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950
Glucagon-like peptide-1 7–36: a physiological incretin in man
Kreymann, B., Ghatei, M. A., Williams, G., & Bloom, S. R. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91194-9 · Cited by 1,928
Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.
Flint, A., Raben, A., Astrup, A., & Holst, J. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci990 · Cited by 1,402
Xu, G., Stoffers, D. A., Habener, J. F., & Bonner-Weir, S. (1999) · Diabetes · doi:10.2337/diabetes.48.12.2270 · Cited by 1,209
Thorens, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.18.8641 · Cited by 906
Drucker, D. J., Philippe, J., Mojsov, S., Chick, W. L., & Habener, J. F. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.10.3434 · Cited by 903
Self-citationMojsov, S., Weir, G. C., & Habener, J. F. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112855 · Cited by 882
Induction of intestinal epithelial proliferation by glucagon-like peptide 2.
Drucker, D. J., Erlich, P., Asa, S. L., & Brubaker, P. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7911 · Cited by 880
Self-citationZulewski, H., Abraham, E. J., Gerlach, M. J., Daniel, P. B., Moritz, W., Müller, B., Vallejo, M., Thomas, M. K., & Habener, J. F. (2001) · Diabetes · doi:10.2337/diabetes.50.3.521 · Cited by 785
Mojsov, S., Heinrich, G., Wilson, I. B., Ravazzola, M., Orci, L., & Habener, J. F. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67324-7 · Cited by 724
Larsen, P. J., Tang-Christensen, M., Holst, J. J., & Ørskov, C. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00434-4 · Cited by 663
Hamster preproglucagon contains the sequence of glucagon and two related peptides
Bell, G. I., Santerre, R. F., & Mullenbach, G. T. (1983) · Nature · doi:10.1038/302716a0 · Cited by 649
Glucagon-like Peptide-1 Receptor Signaling Modulates β Cell Apoptosis
Li, Y., Hansotia, T., Yusta, B., Ris, F., Halban, P. A., & Drucker, D. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209423200 · Cited by 589
Self-citationStoffers, D. A., Kieffer, T. J., Hussain, M. A., Drucker, D. J., Bonner-Weir, S., Habener, J. F., & Egan, J. M. (2000) · Diabetes · doi:10.2337/diabetes.49.5.741 · Cited by 576
Self-citationJeppesen, P. B., Hartmann, B., Thulesen, J., Graff, J., Lohmann, J., Hansen, B. S., Tofteng, F., Poulsen, S. S., Madsen, J. L., Holst, J. J., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.22555 · Cited by 532
Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats
Farilla, L., Hui, H., Bertolotto, C., Kang, E., Bulotta, A., Di Mario, U., & Perfetti, R. (2002) · Endocrinology · doi:10.1210/en.2002-220405 · Cited by 502
Willms, B., Werner, J., Holst, J. J., Orskov, C., Creutzfeldt, W., & Nauck, M. A. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.1.8550773 · Cited by 502
Leri, A., Claudio, P. P., Li, Q., Wang, X., Reiss, K., Wang, S., Malhotra, A., Kajstura, J., & Anversa, P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci316 · Cited by 456
Perfetti, R. (2000) · Endocrinology · doi:10.1210/en.141.12.4600 · Cited by 442
Minireview: The Glucagon-Like Peptides
Drucker, D. J. (2001) · Endocrinology · doi:10.1210/en.142.2.521 · Cited by 421
Self-citationButeau, J., Roduit, R., Susini, S., & Prentki, M. (1999) · Diabetologia · doi:10.1007/s001250051238 · Cited by 413
DeFea, K. A., Vaughn, Z. D., O'Bryan, E. M., Nishijima, D., Déry, O., & Bunnett, N. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190276697 · Cited by 405
ØRSKOV, C., HOLST, J. J., & NIELSEN, O. V. (1988) · Endocrinology · doi:10.1210/endo-123-4-2009 · Cited by 396
Critical Role of cAMP-GEFII·Rim2 Complex in Incretin-potentiated Insulin Secretion
Kashima, Y., Miki, T., Shibasaki, T., Ozaki, N., Miyazaki, M., Yano, H., & Seino, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108378200 · Cited by 381
Protection and Reversal of Excitotoxic Neuronal Damage by Glucagon-Like Peptide-1 and Exendin-4
Perry, T., Haughey, N. J., Mattson, M. P., Egan, J. M., & Greig, N. H. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.037481 · Cited by 380
Tourrel, C., Bailbé, D., Meile, M.-J., Kergoat, M., & Portha, B. (2001) · Diabetes · doi:10.2337/diabetes.50.7.1562 · Cited by 362
Chun, S. Y., Eisenhauer, K. M., Minami, S., Billig, H., Perlas, E., & Hsueh, A. J. W. (1996) · Endocrinology · doi:10.1210/en.137.4.1447 · Cited by 360
Enteroendocrine localization of GLP-2 receptor expression in humans and rodents
Yusta, B., Huang, L., Munroe, D., Wolff, G., Fantaske, R., Sharma, S., Demchyshyn, L., Asa, S. L., & Drucker, D. J. (2000) · Gastroenterology · doi:10.1053/gast.2000.16489 · Cited by 339
Self-citationPrototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2
Munroe, D. G., Gupta, A. K., Kooshesh, F., Vyas, T. B., Rizkalla, G., Wang, H., Demchyshyn, L., Yang, Z.-J., Kamboj, R. K., Chen, H., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1569 · Cited by 328
Self-citationModulation of specific intestinal epithelial progenitors by enteric neurons
Bjerknes, M., & Cheng, H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211278098 · Cited by 325
Intestinal growth-promoting properties of glucagon-like peptide-2 in mice
Tsai, C. H., Hill, M., Asa, S. L., Brubaker, P. L., & Drucker, D. J. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.1.e77 · Cited by 319
Self-citationZhou, J., Wang, X., Pineyro, M. A., & Egan, J. M. (1999) · Diabetes · doi:10.2337/diabetes.48.12.2358 · Cited by 319
Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice
Wang, Q., & Brubaker, P. (2002) · Diabetologia · doi:10.1007/s00125-002-0828-3 · Cited by 312
Abraham, E. J. (2002) · Endocrinology · doi:10.1210/en.143.8.3152 · Cited by 310
Villalba, M., Bockaert, J., & Journot, L. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-01-00083.1997 · Cited by 306
Amling, M., Neff, L., Tanaka, S., Inoue, D., Kuida, K., Weir, E., Philbrick, W. M., Broadus, A. E., & Baron, R. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.136.1.205 · Cited by 304
Pancreatic preproglucagon cDNA contains two glucagon-related coding sequences arranged in tandem
Lund, P. K., Goodman, R. H., Dee, P. C., & Habener, J. F. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.2.345 · Cited by 295
Tourrel, C., Bailbe, D., Lacorne, M., Meile, M.-J., Kergoat, M., & Portha, B. (2002) · Diabetes · doi:10.2337/diabetes.51.5.1443 · Cited by 285
Rolin, B., Larsen, M. O., Gotfredsen, C. F., Deacon, C. F., Carr, R. D., Wilken, M., & Knudsen, L. B. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00030.2002 · Cited by 281
Benjamin, M. A., McKay, D. M., Yang, P.-C., Cameron, H., & Perdue, M. H. (2000) · Gut · doi:10.1136/gut.47.1.112 · Cited by 277
Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV
Drucker, D. J., Shi, Q., Crivici, A., Sumner-Smith, M., Tavares, W., Hill, M., DeForest, L., Cooper, S., & Brubaker, P. L. (1997) · Nature Biotechnology · doi:10.1038/nbt0797-673 · Cited by 276
Self-citationSharma, K. (1996) · Molecular Endocrinology · doi:10.1210/me.10.12.1688 · Cited by 269
Buteau, J., Foisy, S., Rhodes, C. J., Carpenter, L., Biden, T. J., & Prentki, M. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2237 · Cited by 252
GLP-2 augments the adaptive response to massive intestinal resection in rat
Scott, R. B., Kirk, D., MacNaughton, W. K., & Meddings, J. B. (1998) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1998.275.5.g911 · Cited by 237
Glucagonostatic and Insulinotropic Action of Glucagonlike Peptide I-(7–36)-Amide
Komatsu, R., Matsuyama, T., Namba, M., Watanabe, N., Itoh, H., Kono, N., & Tarui, S. (1989) · Diabetes · doi:10.2337/diab.38.7.902 · Cited by 234
Hui, H., Wright, C., & Perfetti, R. (2001) · Diabetes · doi:10.2337/diabetes.50.4.785 · Cited by 223
Pancreatic and intestinal processing of proglucagon in man
Ørskov, C., Holst, J. J., Poulsen, S. S., & Kirkegaard, P. (1987) · Diabetologia · doi:10.1007/bf00274797 · Cited by 210
Kang, G., Chepurny, O. G., & Holz, G. G. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.0375c.xd · Cited by 204
Trumper, A., Trumper, K., & Horsch, D. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1740233 · Cited by 193
Burrin, D. G., Stoll, B., Jiang, R., Petersen, Y., Elnif, J., Buddington, R. K., Schmidt, M., Holst, J. J., Hartmann, B., & Sangild, P. T. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.279.6.g1249 · Cited by 188
Boushey, R. P., Yusta, B., & Drucker, D. J. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.5.e937 · Cited by 179
Self-citationSchjoldager, B. T. G., Mortensen, P. E., Christiansen, J., �rskov, C., & Holst, J. J. (1989) · Digestive Diseases and Sciences · doi:10.1007/bf01540341 · Cited by 178
Human [Gly2]GLP-2 reduces the severity of colonic injury in a murine model of experimental colitis
Drucker, D. J., Yusta, B., Boushey, R. P., DeForest, L., & Brubaker, P. L. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.276.1.g79 · Cited by 176
Self-citationRole of Endogenous Glucagon-Like Peptide-1 in Islet Regeneration After Partial Pancreatectomy
De León, D. D., Deng, S., Madani, R., Ahima, R. S., Drucker, D. J., & Stoffers, D. A. (2003) · Diabetes · doi:10.2337/diabetes.52.2.365 · Cited by 172
Self-citationChen, Y. E., & Drucker, D. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.7.4108 · Cited by 166
Self-citationGomez, E., Pritchard, C., & Herbert, T. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209165200 · Cited by 162
Glucagon-Like Peptide-1 Regulates the Beta Cell Transcription Factor, PDX-1, in Insulinoma Cells
Wang, X., Cahill, C. M., Piñeyro, M. A., Zhou, J., Doyle, M. E., & Egan, J. M. (1999) · Endocrinology · doi:10.1210/endo.140.10.7158 · Cited by 160
HEINRICH, G., GROS, P., LUND, P. K., BENTLEY, R. C., & HABENER, J. F. (1984) · Endocrinology · doi:10.1210/endo-115-6-2176 · Cited by 158
Initiation of Increased Pancreatic Islet Growth in Young Normoglycemic Mice (Umea +/?)
Edvell, A., & Lindström, P. (1999) · Endocrinology · doi:10.1210/endo.140.2.6514 · Cited by 157
Boushey, R. P., Yusta, B., & Drucker, D. J. (2001) · PubMed · Cited by 150
Self-citationAdrenergic regulation of myocardial apoptosis
Singh, K. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00370-3 · Cited by 144
Chen, H.-L., Demiralp, B., Schneider, A., Koh, A. J., Silve, C., Wang, C. Y., & McCauley, L. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108913200 · Cited by 142
Susini, S., Roche, E., Prentki, M., & Schlegel, W. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.12.1173 · Cited by 137
Susini, S., Roche, E., Prentki, M., & Schlegel, W. (1998) · PubMed · Cited by 133
Lezoualc’h, F., Engert, S., Berning, B., & Behl, C. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.1.0403 · Cited by 133
Prevention of parenteral nutrition-induced gut hypoplasia by coinfusion of glucagon-like peptide-2
Chance, W. T., Foley‐Nelson, T., Thomas, I., & Balasubramaniam, A. (1997) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1997.273.2.g559 · Cited by 133
Cholecystokinin Induces Caspase Activation and Mitochondrial Dysfunction in Pancreatic Acinar Cells
Gukovskaya, A. S., Gukovsky, I., Jung, Y., Mouria, M., & Pandol, S. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202929200 · Cited by 132
Skoglund, G., Hussain, M. A., & Holz, G. G. (2000) · Diabetes · doi:10.2337/diabetes.49.7.1156 · Cited by 131
β-Cell Differentiation from a Human Pancreatic Cell Line in Vitro and in Vivo
de la Tour, D. D., Halvorsen, T., Demeterco, C., Tyrberg, B., Itkin‐Ansari, P., Loy, M., Yoo, S.-J., Hao, E., Bossie, S., & Levine, F. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.3.0604 · Cited by 129
Glucagonlike peptide-2 enhances small intestinal absorptive function and mucosal mass in vivo
Kato, Y., Yu, D., & Schwartz, M. Z. (1999) · Journal of Pediatric Surgery · doi:10.1016/s0022-3468(99)90221-x · Cited by 126
Oehler, M. K., Norbury, C. J., Hague, S. J., REES, M. C. P., & Bicknell, R. (2001) · Oncogene · doi:10.1038/sj.onc.1204422 · Cited by 125
Drucker, D. J., DeForest, L., & Brubaker, P. L. (1997) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1997.273.6.g1252 · Cited by 123
Self-citationGut adaptation and the glucagon-like peptides
Drucker, D. J. (2002) · Gut · doi:10.1136/gut.50.3.428 · Cited by 123
Self-citationG-proteins in growth and apoptosis: lessons from the heart
Adams, J. W., & Brown, J. H. (2001) · Oncogene · doi:10.1038/sj.onc.1204275 · Cited by 121
Yusta, B., Boushey, R. P., & Drucker, D. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005510200 · Cited by 114
Self-citationAlavi, K., Schwartz, M. Z., Palazzo, J., & Prasad, R. (2000) · Journal of Pediatric Surgery · doi:10.1053/jpsu.2000.6861 · Cited by 113
Pedersen, W. A., McCullers, D. L., Culmsee, C., Haughey, N. J., Herman, J. P., & Mattson, M. P. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0395 · Cited by 113
Drucker, D. J. (2001) · Current Pharmaceutical Design · doi:10.2174/1381612013397401 · Cited by 113
Self-citationNatriuretic Peptides and Nitric Oxide Induce Endothelial Apoptosis via a cGMP–Dependent Mechanism
Suenobu, N., Shichiri, M., Iwashina, M., Marumo, F., & Hirata, Y. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.1.140 · Cited by 111
Kienlen‐Campard, P., Crochemore, C., René, F., MONNIER, D., Koch, B., & Loeffler, J.-P. (1997) · DNA and Cell Biology · doi:10.1089/dna.1997.16.323 · Cited by 111
Drucker, D. J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.4.7386 · Cited by 107
Self-citationMolecular evolution of proglucagon
Irwin, D. M. (2001) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00232-9 · Cited by 105
Movassat, J., Beattie, G. M., Lopez, A. D., & Hayek, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020137 · Cited by 103
Yusta, B., Somwar, R., Wang, F., Munroe, D. G., Grinstein, S., Klip, A., & Drucker, D. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.30459 · Cited by 103
Self-citationYusta, B., Estall, J. L., & Drucker, D. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201358200 · Cited by 98
Self-citationZhou, J., Piñeyro, M. A., Wang, X., Doyle, M. E., & Egan, J. M. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10143 · Cited by 97
Glucagon-like peptide 1 receptor signaling influences topography of islet cells in mice
Ling, Z., Wu, D., Zambre, Y., Flamez, D., Drucker, D. J., PIPELEERS, D. G., & Schuit, F. C. (2001) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280000374 · Cited by 95
Self-citationD’Alessio, D. A., Fujimoto, W. Y., & Ensinck, J. W. (1989) · Diabetes · doi:10.2337/diab.38.12.1534 · Cited by 85
Molecular mechanisms for the antiapoptotic action of gastrin
Todisco, A., Ramamoorthy, S., Witham, T., Pausawasdi, N., Srinivasan, S., Dickinson, C. J., Askari, F. K., & Krametter, D. F. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.280.2.g298 · Cited by 83
Functional Maturation of Fetal Porcine β-Cells by Glucagon-Like Peptide 1 and Cholecystokinin
Hardikar, A. A., Wang, X. Y., Williams, L. J., Kwok, J. C., Wong, R., Yao, M., & Tuch, B. E. (2002) · Endocrinology · doi:10.1210/en.2001-211344 · Cited by 81
Delgado, M., & Ganea, D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.2.1028 · Cited by 78
Intestinal growth is associated with elevated levels of glucagon-like peptide 2 in diabetic rats
Fischer, K. D., Dhanvantari, S., Drucker, D. J., & Brubaker, P. L. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.4.e815 · Cited by 76
Self-citationPathways of inflammation and cell death in the lung: modulation by vasoactive intestinal peptide
Said, S. I., & Dickman, K. G. (2000) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00174-9 · Cited by 71
Regulation of apoptosis by vasoactive peptides
Filippatos, G. S., Gangopadhyay, N. N., Lalude, O. O., Parameswaran, N., Said, S. I., Spielman, W. S., & Uhal, B. D. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.4.l749 · Cited by 71
Proglucagon-Derived Peptides in Intestinal Epithelial Proliferation
Ghatei, M. A., Goodlad, R. A., Taheri, S., Mandir, N., Brynes, A. E., Jordinson, M., & Bloom, S. R. (2001) · Digestive Diseases and Sciences · doi:10.1023/a:1010615429639 · Cited by 71
Kanno, N., Glaser, S. S., Chowdhury, U., Phinizy, J. L., Baiocchi, L., Francis, H., LeSage, G., & Alpini, G. D. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00025-8 · Cited by 70
Delgado, M., Garrido, E. A. R., Martinez, C., Leceta, J., & Gomariz, R. (1996) · Blood · doi:10.1182/blood.v87.12.5152.bloodjournal87125152 · Cited by 69
Hartmann, B., Thulesen, J., Hare, K. J., Kissow, H., Ørskov, C., Poulsen, S. S., & Holst, J. J. (2002) · Regulatory Peptides · doi:10.1016/s0167-0115(02)00013-7 · Cited by 66
Scrocchi, L. A., Hill, M. E., Saleh, J., Perkins, B. A., & Drucker, D. J. (2000) · Diabetes · doi:10.2337/diabetes.49.9.1552 · Cited by 60
Self-citationGlucagonlike peptide-2 analogue enhances intestinal mucosal mass after ischemia and reperfusion
Prasad, R., Alavi, K., & Schwartz, M. Z. (2000) · Journal of Pediatric Surgery · doi:10.1016/s0022-3468(00)90040-x · Cited by 59
Goswami, R., Dawson, S. A., & Dawson, G. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70041376.x · Cited by 54
Glucagon and Related Peptides in Fetal Rat Hypothalamusin Vivoandin Vitro*
Lui, E. Y. T., Asa, S. L., Drucker, D. J., Lee, Y. C., & BRUBAKER, P. L. (1990) · Endocrinology · doi:10.1210/endo-126-1-110 · Cited by 52
Self-citationChance, W. T., Sheriff, S., Foley‐Nelson, T., Thomas, I., & Balasubramaniam, A. (2000) · Nutrition and Cancer · doi:10.1207/s15327914nc372_15 · Cited by 37
Calcitonin gene-related peptide enhances apoptosis of thymocytes
Sakuta, H., Inaba, K., & Muramatsu, S. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(96)00053-7 · Cited by 33
Cited by
Biology of Incretins: GLP-1 and GIP
Baggio, L. L., & Drucker, D. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.054 · Cited by 3,639
Self-citationAlbumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
Kratz, F. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.010 · Cited by 2,151
Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120
Hirasawa, A., Tsumaya, K., Awaji, T., Katsuma, S., Adachi, T., Yamada, M., Sugimoto, Y., Miyazaki, S., & Tsujimoto, G. (2005) · Nature Medicine · doi:10.1038/nm1168 · Cited by 1,545
Pharmacology, physiology, and mechanisms of incretin hormone action.
Campbell, J. E., & Drucker, D. J. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.008 · Cited by 1,500
Self-citationImpact of albumin on drug delivery — New applications on the horizon
Elsadek, B., & Kratz, F. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.069 · Cited by 832
Metadata
- Authors
- Drucker, D. J.
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2003-02-01
- Volume
- 17
- Issue
- 2
- Pages
- 161-171
- ISSN
- 0888-8809 (ISSN-L)
- 1944-9917
- OpenAlex
- W2107076497
- Cited by
- 483
- References
- 105
- FWCI
- 34.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.